Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant women
RU 486 is a synthetic steroid which acts as an antiprogestin at the receptor level. The clinical usefulness of the compound for menstrual regulation and termination of early pregnancy is currently being evaluated. The aim of the present study was to determine the plasma levels of RU 486 following the oral administration of the compound to 42 pregnant and 10 non-pregnant women. The levels of RU 486 were measured by a radioimmunoassay method which uses chromatography on Sephadex LH 20 columns. The identity of the compound assayed as RU 486 was confirmed, but the presence of small amounts of two highly cross-reacting metabolites (monodemethyl and didemethyl RU 486) in the analyzed fractions could not be excluded. Following the ingestion of a single tablet containing 25 and 50 mg of the compound, a peak plasma value of approximately 3.5 to 4.0 mumol/l in both the pregnant and non-pregnant subjects was reached one to two hours later. The half-lives of elimination were about 20 hours in both the pregnant and the non-pregnant women. Following the repeated oral administration of 50, 100 or 200 mg of RU 486 daily for four days, maximum plasma levels of 2.9, 4.5 and 5.4 mumol/l, respectively, were found. Thus, the increase in plasma levels was not directly proportional to the increase in the dose. No accumulation of RU 486 in the plasma was found, even when the duration of treatment was prolonged to six days. The data partly explain the reported lack of relation between ingested dose and frequency of induced abortion and they may be useful for designing future studies on the use of compound to prevent implantation, induce menstruation or terminate an early pregnancy.
- Research Organization:
- Karolinska Hospital, Stockholm, Sweden
- OSTI ID:
- 6592431
- Journal Information:
- Contraception; (United States), Vol. 5
- Country of Publication:
- United States
- Language:
- English
Similar Records
Physiologically based pharmacokinetic modeling of the pregnant rat: A multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. (Reannouncement with new availability information). Interim report, April 1986-December 1988
Effect of antiprogestin ZK 98. 734 on the ovarian cycle, early pregnancy, and on its binding to progesterone receptors in the myometrium of marmoset Callithrix jacchus
Related Subjects
STEROIDS
RADIOIMMUNOASSAY
ABORTION
BIOCHEMICAL REACTION KINETICS
BIOLOGICAL HALF-LIFE
BODY BURDEN
LIQUID COLUMN CHROMATOGRAPHY
MENSTRUAL CYCLE
ORAL ADMINISTRATION
PREGNANCY
WOMEN
ANIMALS
CHROMATOGRAPHY
FEMALES
IMMUNOASSAY
IMMUNOLOGY
ISOTOPE APPLICATIONS
KINETICS
MAMMALS
MAN
ORGANIC COMPOUNDS
PRIMATES
RADIOASSAY
RADIOIMMUNOLOGY
REACTION KINETICS
SEPARATION PROCESSES
TRACER TECHNIQUES
VERTEBRATES
550601* - Medicine- Unsealed Radionuclides in Diagnostics